IT Intelligence Bulletin – Accenture has announced a collaborative services agreement with Roche.

Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.

A tumor board is a meeting in which multi-disciplinary healthcare teams review and discuss individual cancer patient cases and available treatment options. The NAVIFY Tumor Board solution streamlines and standardizes the tumor board workflow process by aggregating relevant patient data from disparate IT systems into a software solution that fosters efficient team collaboration, reduces errors, and gives the care team more time to evaluate individual patient cases.

The data integration capabilities Accenture provides will allow Roche to integrate patient data between hospitals and the NAVIFY Tumor Board solution to support clinicians in arriving at the best possible treatment decisions for their patients. The NAVIFY Tumor Board solution is built on a secure cloud platform.

This report continues after the following message from HG Insights:

HG Insights – Sourcing Intelligence Redefined

HG Insights provides deep sourcing intelligence and diagnostic tools on and for the IT industry, analyzing the sector’s supply and purchasing activities to identify points of significant business value for enterprise companies and the vendors that serve them.

If you would like to get more insight into the collaboration between Accenture and Roche, gain unique account-level intelligence on these companies or identify opportunities across the wider IT market – Contact us now.

“Our collaboration with Accenture is another exciting step forward in providing personalized healthcare solutions to patients,” said Tim M. Jaeger, Global Head of Diagnostics Information Solutions for Roche. “Tumor board coordination is labor intensive and time consuming for healthcare providers. Accenture’s global scale, deep digital expertise, and innovation capabilities in the healthcare and life sciences industries allows Roche to continue our focus on delivering workflow and decision support solutions to customers and improving patient outcomes.”

Andrea Brückner, who leads Accenture’s Life Sciences practice in Europe, said: “With Roche, we continue to provide meaningful impact on patients’ lives by combining new science with leading-edge technology to revolutionize patient care. By providing data integration services to the NAVIFY Tumor Board solution, we aim to ensure that all available data is used to accelerate and optimize treatment decisions for cancer patients.”

Send HG Insights your news

Have you got IT news you would like the HG Insights news team to cover? Maybe you have the inside track on a major IT news story or have heard something significant or of interest to the global IT sector. We value all contributions.

Email all press releases / information to News@HGInsights.com and one of our journalists will get back to you.